SCPC Praises CMS Recognition of Unique Characteristics of LTC Patient Population
WASHINGTON, April 10, 2018 — Commenting broadly on the Center for Medicare and Medicaid Services’ (CMS) Final Rule modifying Medicare Part D regulations as well as the Final Part D Call Letter for 2019, the Senior Care Pharmacy Coalition (SCPC) praised the agency for its recognition of the unique needs of long-term care (LTC) patients, and the stringent safeguards employed by LTC pharmacies in the context of opioid control and distribution.
“We are particularly gratified that the agency modified opioid control provisions based on the unique characteristics of long-term care patients and the heightened controls that long-term care pharmacies provide,” stated Alan G. Rosenbloom, President and CEO of the SCPC, the only Washington-based organization exclusively representing the interests of long-term care (LTC) pharmacies and the patients they serve.
Rosenbloom said that while other provisions do not appropriately distinguish between long-term care settings and community settings — which threaten continuity of care for Medicare beneficiaries — the overall changes help set the stage for a subsequent policy discussion surrounding the need to establish a specific federal definition of LTC pharmacies.
“SCPC is pleased that the regulatory community, as well as Congress, is increasingly aware of the significant structural and operational differences between LTC pharmacies and retail pharmacies,” Rosenbloom continued. “It is important to specifically codify these differences for the benefit of patients, the broader health community and taxpayers. We look forward to sustaining this policy discussion thorough 2018.”
The SCPC President and CEO also said the LTC pharmacy advocacy group appreciates CMS Administrator Seema Verma’s consideration of inappropriate fees and other payment adjustments that Part D Plans and their affiliated pharmacy benefits managers (PBMs) unjustifiability impose on long-term care pharmacies.
“These practices increase drug costs for beneficiaries and the Medicare program, and we look forward to the Trump Administration’s anticipated plan to respond to high drug prices.”
###
The SCPC is the national association for independent LTC pharmacies. Our member pharmacies provide care and services to patients in LTC facilities across the country occupying approximately 750,000 beds. Visit seniorcarepharmacies.org to learn more.
Recent Posts
-
SCPC Releases Third Installment of Video Series on the Unique Role of Long-Term Care Pharmacies
Long‑term care pharmacies play a specialized and indispensable role in supporting seniors and medically complex patients across the country. Unlike traditional retail pharmacies, LTC pharmacies provide coordinated, around‑the‑clock clinical support, enhanced medication management, and seamless collaboration with caregivers and providers to ensure continuity of care for those who need it most. This week’s featured video […]
-
SCPC Urges CMS Not to Apply Retail Drug Pricing Benchmarks to Long-Term Care Pharmacies
On November 2, 2026, the Senior Care Pharmacy Coalition (SCPC) submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to the agency’s proposed extension of the information collection associated with the National Average Drug Acquisition Cost (NADAC) survey. While supporting efforts to improve transparency in prescription drug pricing, SCPC emphasized that […]
-
SCPC Releases New Video on the Next Chapter for Long-Term Care Pharmacy
SCPC’s new video, ‘LTC Pharmacy is Rising’, explores how we’re turning our sector’s growing momentum into a strong voice in Washington. Behind every LTC pharmacy are people committed to caring for our country’s most vulnerable patients. Hear from SCPC’s President & CEO, Esmé Grewal, and VP of Government Relations, Shara Selonick, about what drives their […]
Stay Connected
Get the latest news and updates on issues impacting the long-term care pharmacy community.